Create an Account
  1. Home
  2. Specialty
  3. General Ophthalmology

KOL KNOCKOUT™: Oculoplastics Edition – Sculpting Sight For Patients With Thyroid Eye Disease - Round 1

ReachMD Healthcare Image
Program Information
Take Pre-Test

Thank you for attending. The posttest will not be available immediately.


Note for ODs: COPE guidelines dictate that in order to receive credit, learners must remain present at the synchronous virtual activity until the end of the program. Attendees who meet the required instructional time established by COPE will receive an email with a link to obtain credit within 48 hours of the program's completion.

Scroll back to top
Details

  • Overview

    Step into the ring for the inaugural KOL KNOCKOUT™ in Oculoplastics! Experts Nicholas Robert Mahoney, MD; Amina Malik, MD; and Prem S. Subramanian, MD, PhD, will go head-to-head on thyroid eye disease. With Program Chair Andrew R. Harrison, MD, overseeing the action, this symposium will include fierce competition as they dissect clinical cases and advocate for their preferred management approaches. It's a fight to the finish, where you, the learner, will decide whose strategies reign supreme!

    Note About Obtaining Credit:
    You must attend the course in its entirety.
    COPE guidelines dictate that in order to receive credit, learners must remain present at the synchronous virtual symposium until the end of the program. Attendees who meet the required instructional time established by COPE will receive an email with a link to obtain credit within 48 hours of the program's completion.

     

    This activity is supported by an unrestricted educational grant from Amgen.

     

  • Learning Objectives

    Upon completion of this activity, the participant should be able to:

    • Conduct comprehensive clinical assessments, including the appropriate use of laboratory tests and radiologic imaging, to recognize the heterogenous presentation of thyroid eye disease and ascertain potential thyroid dysfunction
    • Propose medically relevant treatment regimens together with customized surgical approaches to address the physical burden and reduced quality of life due to thyroid eye disease
    • Formulate effective comanagement strategies with relevant health care professionals to optimize treatment outcomes and manage adverse events

    • Accreditation

      Provided by Evolve Medical Education 

      Evolve is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
      Evolve designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

      Evolve Medical Education LLC (Evolve) is a COPE-accredited administrator. 

      This activity, COPE Activity Number 128496 is accredited by COPE for continuing education for optometrists. This course is approved for 1.5 hours of CE.

      Course #: 91541-SD
      Activity #: 128496

      COPE advises optometrists to contact the State or Provincial Board where they are licensed for verification of what is acceptable for license renewal.

    • Participation Method

      In order to obtain credit, proceed through the program, complete the posttest, evaluation and submit for credit.

      Course Viewing Requirements

      Supported Browsers:
      Internet Explorer 11 for Windows
      Edge (recent versions; Chromium-based) for Windows
      Google Chrome (recent versions) for Windows, Mac OS, iOS, Android, or Linux
      Mozilla Firefox (recent versions) for Windows, Mac OS, iOS, Android, or Linux
      Safari (recent versions) for Mac OSX, or iOS

      Hardware Requirements:
      4GB+ RAM
      Recommended internet speed 5Mbps+

    • Faculty and Disclosures

      Andrew R. Harrison, MD

      Andrew R. Harrison, MD

      Professor of Ophthalmology
      and Otolaryngology
      Director, Oculofacial Plastic
      and Orbital Surgery
      Vice Chair, Surgical Services and Quality
      Co-director, Center for Thyroid Eye Disease
      University of Minnesota
      Minneapolis, MN


      Nicholas Robert Mahoney, MD

      Nicholas Robert Mahoney, MD

      Chief, Oculoplastics Division
      The Johns Hopkins Hospital
      Associate Professor of Ophthalmology
      Johns Hopkins Wilmer Eye Institute
      Baltimore, MD


      Amina Malik, MD

      Amina Malik, MD

      Associate Professor of Clinical Ophthalmology
      Chief of Ophthalmic Plastic and Reconstructive Surgery
      Houston Methodist Hospital
      Weill Cornell Medical College
      Houston, TX


      Prem S. Subramanian, MD, PhD

      Prem S. Subramanian, MD, PhD

      Clifford R. and Janice N. Merrill
      Endowed Chair in Ophthalmology
      Professor of Ophthalmology, Neurology,
      and Neurosurgery
      Vice Chair for Academic Affairs
      Sue Anschutz-Rodgers
      University of Colorado Eye Center
      Aurora, CO


      DISCLOSURE POLICY
      It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent financial relationships relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all financial relationships prior to this educational activity.

      The following faculty/staff members have the following financial relationships with ineligible companies.

      Andrew R. Harrison, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Amgen, Horizon Therapeutics, Lassen Therapeutics, RVL, and Viridian Therapeutics. Grant/Research Support: Viridian Therapeutics. Speaker's Bureau: Amgen, Horizon Therapeutics, and RVL.

      Nicholas Robert Mahoney, MD, has had no financial relationships or affiliations with ineligible companies.

      Amina Malik, MD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Horizon Therapeutics. Speaker's Bureau: Horizon Therapeutics.

      Prem S. Subramanian, MD, PhD, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Acelyrin, Alexion, GenSight Biologics, Horizon Therapeutics, Invex Therapeutics, Kriya Therapeutics, Neurophth Therapeutics, Tourmaline Bio, and Viridian Therapeutics. Grant/Research Support: Department of Defense, Horizon Therapeutics, and National Institutes of Health. Independent Contractor: GenSight Biologics, Horizon Therapeutics, Immunovant, Invex Therapeutics, Neurophth Therapeutics, Tourmaline Bio, and Viridian Therapeutics.

      The Evolve staff, planners and peer reviewer have no financial relationships with ineligible companies.

    • Disclaimer

      OFF-LABEL STATEMENT
      This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

      DISCLAIMER
      The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve or Amgen.

      This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

      Note About Obtaining Credit:
      You must attend the course in its entirety.
      COPE guidelines dictate that in order to receive credit, learners must remain present at the synchronous virtual symposium until the end of the program. Attendees who meet the required instructional time established by COPE will receive an email with a link to obtain credit within 48 hours of the program's completion.

    • System Requirements

      • Supported Browsers (2 most recent versions):
        • Google Chrome for Windows, Mac OS, iOS, and Android
        • Apple Safari for Mac OS and iOS
        • Mozilla Firefox for Windows, Mac OS, iOS, and Android
        • Microsoft Edge for Windows
      • Recommended Internet Speed: 5Mbps+

    • Publication Dates

      Expiration Date:

    1.50 credits
    Completing the pre-test is required to access this content.
    Completing the pre-survey is required to view this content.

    Ready to Claim Your Credits?

    You have attempts to pass this post-test. Take your time and review carefully before submitting.

    Good luck!

    LIVE ON REACHMD RADIOBack to live radio
    ReachMD Radio

    Loading...

    00:00
    00:00
      Register

      We're glad to see you're enjoying Evolve Medical Education…
      but how about a more personalized experience?

      Register for free